Inhibition of colonic aberrant crypt formation by the dietary flavonoids (+)-catechin and hesperidin.
Franke
Adrian A
AA
Cancer Research Center of Hawaii, Honolulu 96813, USA. adrian@crch.hawaii.edu
Custer
Laurie J
LJ
Cooney
Robert V
RV
Tanaka
Yuichiro
Y
Xu
Meirong
M
Dashwood
Roderick H
RH
D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001628:Beverages / Q000032:analysis; D002273:Carcinogens / Q000633:toxicity; D002392:Catechin / Q000494:pharmacology* / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D002957:Citrus / Q000737:chemistry; D003106:Colon / Q000187:drug effects* / Q000473:pathology; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D004032:Diet; D004353:Drug Evaluation, Preclinical; D005504:Food Analysis; D006569:Hesperidin / Q000494:pharmacology* / Q000627:therapeutic use; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000473:pathology; D008297:Male; D015394:Molecular Structure; D011804:Quinolines / Q000633:toxicity; D051381:Rats; D011916:Rats, Inbred F344; D013662:Tea / Q000737:chemistry; D014920:Wine / Q000032:analysis
D016588:Anticarcinogenic Agents; D002273:Carcinogens; D011804:Quinolines; D013662:Tea; C029216:2-amino-3-methylimidazo(4,5-f)quinoline; D002392:Catechin; D006569:Hesperidin